glp-1 names 5 trends to expect in 2026: Expanded uses, oral options, and more glp-1 receptor agonist drug names

The market is projected to reach USD 70.08 billion in 2025 and USD 156.71 billion by 2030, expanding at a compound annual growth rate (CAGR) of 17.46% from 2025 to 2030 (Figure 2)

Her research has been recognized internationally with honors such as the Princess of Asturias Award, the Tang Prize, the VinFuture Prize for Innovation from Vietnam and the BBVA Foundation Frontiers of Knowledge Award

The primary endpoint was a composite of CV death, nonfatal MI, nonfatal stroke, and hospitalization for unstable angina

There is a major increased risk of gallbladder inflammation (cholecystitis) gallstones and pancreatitis

6.11.1 Steroidogenesis One of the main characteristics of PCOS patients is HA, and the ovarian theca cells are thought to be one of the major sources of excess androgen in PCOS patients (311)

While the main competition will likely remain between Victoza and Trulicity, several developments could impact the market, such as introduction of generic versions of Byetta and approval of Ozempic